Diffusion Pharmaceuticals Inc.

NasdaqCM:DFFN Stock Report

Mkt Cap: US$12.3m

Diffusion Pharmaceuticals Future Growth

How is Diffusion Pharmaceuticals forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


21.4%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

NasdaqCM:DFFN - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20253-15N/AN/A1
12/31/2024N/A-18N/AN/A2
12/31/2023N/A-17N/AN/A2
9/30/2022N/A-15-15-15N/A
6/30/2022N/A-24-15-15N/A
3/31/2022N/A-24-14-14N/A
12/31/2021N/A-24-15-15N/A
9/30/2021N/A-25-15-15N/A
6/30/2021N/A-17-15-15N/A
3/31/2021N/A-18-15-15N/A
12/31/2020N/A-16-14-14N/A
9/30/2020N/A-16-13-13N/A
6/30/2020N/A-14-11-11N/A
3/31/2020N/A-12-11-11N/A
12/31/2019N/A-12-10-10N/A
9/30/2019N/A-14-10-10N/A
6/30/2019N/A-18-10-10N/A
3/31/2019N/A-18-10-10N/A
12/31/2018N/A-27-11-11N/A
9/30/2018N/A-20-10-10N/A
6/30/2018N/A-10-12-12N/A
3/31/2018N/A4-13-12N/A
12/31/2017N/A-3-13-12N/A
9/30/2017N/A-7-12-11N/A
6/30/2017N/A-15-10-9N/A
3/31/2017N/A-30-10-10N/A
12/31/2016N/A-18-11-11N/A
9/30/2016N/A-18-12-12N/A
6/30/2016N/A-14N/A-11N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: DFFN is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: DFFN is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: DFFN is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: DFFN is forecast to have no revenue next year.

High Growth Revenue: DFFN is forecast to have no revenue next year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if DFFN's Return on Equity is forecast to be high in 3 years time


Discover growth companies